melatonin and devazepide

melatonin has been researched along with devazepide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X1
Bonouali-Pellissier, S1
Jaworek, J; Konturek, SJ; Leja-Szpak, A; Nawrot, K; Pawlik, WW; Thor, P1
Acuña-Castroviejo, D; Escames, G; García-Navarro, A; González-Puga, C; León, J; López-Cantarero, M; Ros, E1

Other Studies

4 other study(ies) available for melatonin and devazepide

ArticleYear
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship

2008
Melatonin is involved in cholecystokinin-induced changes of ileal motility in rats.
    Journal of pineal research, 1994, Volume: 17, Issue:2

    Topics: Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Electromyography; Gastrointestinal Motility; Ileum; Indoleacetic Acids; Male; Melatonin; Muscle, Smooth; Pineal Gland; Rats; Rats, Wistar; Receptors, Cholecystokinin; Thiazoles

1994
Melatonin and its precursor, L-tryptophan: influence on pancreatic amylase secretion in vivo and in vitro.
    Journal of pineal research, 2004, Volume: 36, Issue:3

    Topics: Amylases; Animals; Benzodiazepines; Capsaicin; Cells, Cultured; Cholecystokinin; Devazepide; Dose-Response Relationship, Drug; Melatonin; Pancreas; Pancreatic Juice; Rats; Rats, Wistar; Receptors, Melatonin; Tryptamines; Tryptophan; Vagotomy; Vagus Nerve

2004
Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin.
    Journal of pineal research, 2005, Volume: 39, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Devazepide; Dose-Response Relationship, Drug; Drug Synergism; Gastrins; Growth Inhibitors; HT29 Cells; Humans; Melatonin; Proglumide; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Sincalide

2005